TY - JOUR
T1 - One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology
AU - Talarico, Giovanni Paolo
AU - Burzotta, Francesco
AU - Trani, Carlo
AU - Tommasino, Antonella
AU - Niccoli, Giampaolo
AU - Porto, Italo
AU - Leone, Antonio Maria
AU - Mongiardo, Rocco
AU - Schiavoni, Giovanni
AU - Crea, Filippo
PY - 2013
Y1 - 2013
N2 - Polymer-coating represents a key component of drug-eluting stent (DES) technology and its possible impact on vessel-wall healing is a matter of debate. The clinical impact of different polymer-coating may be assessed by comparing the outcome of patients treated by DES having the same stent platform and drug, and differing in the polymer. Thus, we compared the clinical outcome of patients treated by Endeavor Zotarolimus-eluting stent (E-ZES) and Resolute Zotarolimus-eluting stent (R-ZES) as they differ in the polymer-coating only.
AB - Polymer-coating represents a key component of drug-eluting stent (DES) technology and its possible impact on vessel-wall healing is a matter of debate. The clinical impact of different polymer-coating may be assessed by comparing the outcome of patients treated by DES having the same stent platform and drug, and differing in the polymer. Thus, we compared the clinical outcome of patients treated by Endeavor Zotarolimus-eluting stent (E-ZES) and Resolute Zotarolimus-eluting stent (R-ZES) as they differ in the polymer-coating only.
KW - percutaneus coronary interventions
KW - zotarolimus eluting-stents
KW - percutaneus coronary interventions
KW - zotarolimus eluting-stents
UR - http://hdl.handle.net/10807/41467
U2 - 10.1002/ccd.24498
DO - 10.1002/ccd.24498
M3 - Article
SN - 1522-726X
VL - 81
SP - 268
EP - 273
JO - Catheterization and Cardiovascular Interventions
JF - Catheterization and Cardiovascular Interventions
ER -